HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)
South Korea
· Delayed Price · Currency is KRW
23,200
-200 (-0.85%)
Dec 19, 2024, 3:00 PM KST
HLB Pharmaceutical Revenue
In the year 2019, HLB Pharmaceutical had annual revenue of 36.10B KRW with 75.75% growth. HLB Pharmaceutical had revenue of 9.89B in the quarter ending December 31, 2019, with 49.61% growth.
Revenue
36.10B
Revenue Growth
+75.75%
P/S Ratio
8.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
320.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2019 | 36.10B | 15.56B | 75.75% |
Dec 31, 2018 | 20.54B | 4.98B | 32.03% |
Dec 31, 2017 | 15.56B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition